Mikhail Blagosklonny is one of the world’s foremost experts on cancer treatments and research into anti-aging methods. Mikhail currently sits as the Professor of Oncology at the Roswell Park Cancer Institute. Throughout his extensive career he has primarily focused his research and application efforts to target cancer treatments. He is also well known for his research efforts into anti-aging and his advocacy that the potential for the cancer drug Rapamycin to be used to prevent aging exists through TOR signaling and its effect on cancer and the aging process.
Blagosklonny acquired his M.D. as well as his PhD in experimental medicine and cardiology from the First Pavlov State Medical University in St. Petersburg, Russia. He has served as the associate professor of medicine at New York Medical College as well as a senior scientist at Ordway Research Institute in Albany, NY, before taking on his current role at Roswell Park Cancer Institute.
Mikhaul sits as a member of the editorial board for Cell Death & Differentiation, associate editor of Cancer Biology & Therapy and is editor-in-chief of Cell Cycle, Oncotarget and Aging. Mikhail is extremely active when it comes to submitting research papers and has currently over 270 citations to his credit.
His passion for cancer research led him into targeted cancer treatment research focused on studying therapies that keep normal cells from being damaged by the radioactive rays and chemotherapy methods used. He has also worked extensively to research molecular and cellular biology and signal transduction.
Mikhail Blagosklonny has used his vast depth of knowledge born out of his passionate research into cancer treatments and therapies to evolve the hypothesis that the TOR (Target of Rapamycin) pathways can cause quiescent cells to convert to senescent cells without any damage on a molecular level to the cell. This theory would then mean that the drug Rapamycin could potentially be used to reverse the effects of aging that occur naturally.
Throughout his life Mikhail has let his passionate curiosity and interest in targeted cancer treatments and anti-aging lead him down a path that may well have the ultimate destination of a form of immortality for the human race. Visit ResearchGate.Net to learn more about Mikhail’s latest work.